Skip to main content

Market Overview

Bank of America Initiates Aduro BioTech With Buy


Analysts at Bank of America initiated coverage on Aduro BioTech Inc (NASDAQ: ADRO) with a Buy rating.

The target price for Aduro BioTech is set to $40.

Aduro BioTech shares rose 1.46 percent to $31.30 in pre-market trading.

Latest Ratings for ADRO

Jan 2020SVB LeerinkMaintainsOutperform
Jan 2020Cowen & Co.DowngradesOutperformMarket Perform
Dec 2019H.C. WainwrightMaintainsBuy

View More Analyst Ratings for ADRO
View the Latest Analyst Ratings


Related Articles (ADRO)

View Comments and Join the Discussion!

Posted-In: Bank of AmericaInitiation Analyst Ratings

Latest Ratings

ICADGuggenheimInitiates Coverage On24.0
SMBKRaymond JamesUpgrades27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at